ReCode Therapeutics
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics. Its selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. The company aims to leverage innovative technologies to provide solutions for individuals affected by genetic diseases.
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does ReCode Therapeutics use?+
We have not yet detected technologies for ReCode Therapeutics.
What industry is ReCode Therapeutics in?+
ReCode Therapeutics operates in the Biopharma industry.
Where is ReCode Therapeutics based?+
ReCode Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026